BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND MYD88, Q99836, MYD88D, 4615 AND Prognosis
34 results:

  • 1. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
    Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
    Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multiple Genomic Alterations, Including a Novel
    Sahin Y; Wang YL; Pei J; Mansoor N; Styler M; Testa JR; Nejati R
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203475
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Chronic Lymphocytic leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
    Grants JM; May C; Bridgers J; Huang S; Gillis S; Meissner B; Boyle M; Ben-Neriah S; Hung S; Duns G; Hilton L; Gerrie AS; Marra M; Kridel R; Sabatini PJB; Steidl C; Scott DW; Karsan A
    Clin Chem; 2024 Jan; 70(1):273-284. PubMed ID: 38175592
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular characteristics in Chinese with chronic lymphocytic leukemia by next-generation sequencing: A single-center retrospective analysis.
    Cao Y; Chen Y; Tao T; Gong Y; Xu C; Cen J; Shen H; Pan J; Chen S; Yao L
    Int J Lab Hematol; 2023 Dec; 45(6):908-916. PubMed ID: 37551448
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
    Russler-Germain DA; Krysiak K; Ramirez C; Mosior M; Watkins MP; Gomez F; Skidmore ZL; Trani L; Gao F; Geyer S; Cashen AF; Mehta-Shah N; Kahl BS; Bartlett NL; Alderuccio JP; Lossos IS; Ondrejka SL; Hsi ED; Martin P; Leonard JP; Griffith M; Griffith OL; Fehniger TA
    Blood Adv; 2023 Sep; 7(18):5524-5539. PubMed ID: 37493986
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors.
    Aldea M; Tagliamento M; Bayle A; Vasseur D; Vergé V; Marinello A; Danlos FX; Blanc-Durand F; Bernard E; Cerbone L; Mosele MF; Renneville A; Hadoux J; Loriot Y; Sakkal M; Vozy A; Sarkozy C; Smolenschi C; Nicotra C; Martin-Romano P; Boccon-Gibod C; Habza W; Lazarovici J; Ponce S; Hollebecque A; Marzac C; Lacroix L; Barlesi F; André F; Besse B; Rouleau E; Italiano A; Micol JB
    JCO Precis Oncol; 2023 Mar; 7():e2200583. PubMed ID: 36862966
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genetic and Clinical Characteristics of Korean Chronic Lymphocytic leukemia Patients with High Frequencies of
    Ahn A; Kim HS; Kim TY; Lee JM; Kang D; Yu H; Lee CY; Kim Y; Eom KS; Kim M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834590
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Case report: A rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with KMT2D and MECOM mutations.
    Wang L; Tang J; Feng J; Huang Y; Cheng Y; Xu H; Miao Y
    Front Immunol; 2022; 13():1001482. PubMed ID: 36325357
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma.
    Wang X; Hong Y; Meng S; Gong W; Ren T; Zhang T; Liu X; Li L; Qiu L; Qian Z; Zhou S; Zhao M; Zhai Q; Meng B; Ren X; Zhang H; Wang X
    Clin Immunol; 2022 Oct; 243():109105. PubMed ID: 36055572
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Chronic lymphocytic leukemia with t (14;18) (q32;q21) : report of eight cases and a literature review].
    Li J; Zhang HR; Qiu H; Yang R; Guo Y; Miao HY; Zhu L; Wang L; Fan W; Xu JY
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jul; 42(7):577-582. PubMed ID: 34455745
    [No Abstract]    [Full Text] [Related]  

  • 11. [Nodal lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia: a clinicopathological and prognostical study].
    Zhang DD; Hu PZ; Li P; Jiang GZ; Yin YH; Wang GN; Zhao WG; Zhang YP; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):592-597. PubMed ID: 34078045
    [No Abstract]    [Full Text] [Related]  

  • 12. Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia.
    Wang Y; Gali VL; Xu-Monette ZY; Sano D; Thomas SK; Weber DM; Zhu F; Fang X; Deng M; Zhang M; Hagemeister FB; Li Y; Orlowski RZ; Lee HC; Young KH
    Neoplasia; 2021 Apr; 23(4):361-374. PubMed ID: 33735664
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A reduced panel of eight genes (ATM, SF3B1, NOTCH1, BIRC3, XPO1, myd88, TNFAIP3, and TP53) as an estimator of the tumor mutational burden in chronic lymphocytic leukemia.
    Chauzeix J; Pastoret C; Donaty L; Gachard N; Fest T; Feuillard J; Rizzo D
    Int J Lab Hematol; 2021 Aug; 43(4):683-692. PubMed ID: 33325634
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Toll-like receptor 4 signaling pathway is correlated with pathophysiological characteristics of AML patients and its inhibition using TAK-242 suppresses AML cell proliferation.
    Baakhlagh S; Kashani B; Zandi Z; Bashash D; Moradkhani M; Nasrollahzadeh A; Yaghmaei M; Mousavi SA; Ghaffari SH
    Int Immunopharmacol; 2021 Jan; 90():107202. PubMed ID: 33278749
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma.
    Lantermans HC; Minderman M; Kuil A; Kersten MJ; Pals ST; Spaargaren M
    Leukemia; 2021 Mar; 35(3):881-886. PubMed ID: 32591642
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia.
    Shi K; Sun Q; Qiao C; Zhu H; Wang L; Wu J; Wang L; Fu J; Young KH; Fan L; Xia Y; Xu W; Li J
    Cancer Med; 2020 Feb; 9(3):999-1007. PubMed ID: 31849198
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cytological diagnosis of vitreoretinal lymphomas: A case series.
    Quintyn JC; Olle P; Courtade-Saidi M; Laurent C; Obéric L; Quintyn-Ranty ML
    Cytopathology; 2019 Jul; 30(4):385-392. PubMed ID: 31033057
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. 1q23.1 homozygous deletion and downregulation of Fc receptor-like family genes confer poor prognosis in chronic lymphocytic leukemia.
    Daniele G; L'Abbate A; Turchiano A; Palumbo O; Carella M; Lo Cunsolo C; Iuzzolino P; Lonoce A; Hernández-Sánchez M; Minoia C; Leone P; Hernandez-Rivas JM; Storlazzi CT
    Clin Exp Med; 2019 May; 19(2):261-267. PubMed ID: 30877410
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mutational and cytogenetic analyses of 188 CLL patients with trisomy 12: A retrospective study from the French Innovative leukemia Organization (FILO) working group.
    Roos-Weil D; Nguyen-Khac F; Chevret S; Touzeau C; Roux C; Lejeune J; Cosson A; Mathis S; Feugier P; Leprêtre S; Béné MC; Baron M; Raynaud S; Struski S; Eclache V; Sutton L; Lesty C; Merle-Béral H; Cymbalista F; Ysebaert L; Davi F; Leblond V;
    Genes Chromosomes Cancer; 2018 Nov; 57(11):533-540. PubMed ID: 30203893
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinical features and prognosis of 17 patients with primary cold agglutinin disease].
    Wu YY; Cao XX; Cai H; Zhang L; Zhou DB; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2017 Sep; 38(9):789-793. PubMed ID: 29081197
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 2.